Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
2019
Abstract Background The use of adjuvant chemotherapy in patients with breast cancer may be guided by clinicopathological factors and a score based on a 21-gene assay to determine the risk of recurr...
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
41
References
169
Citations
NaN
KQI